Who.int. Cancer. 2022. [online] Available at: https://www.who.int/news-room/fact-sheets/detail/cancer. Accessed 22 Feb 2022.
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological Principles of Metastasis. Cell. 2017;168(4):670–91. https://doi.org/10.1016/j.cell.2016.11.037.
CAS Article PubMed PubMed Central Google Scholar
Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285(21):1182–6. https://doi.org/10.1056/NEJM197111182852108.
CAS Article PubMed Google Scholar
Qin S, Li A, Yi M, Yu S, Zhang M, Wu K. Recent advances on antiangiogenesis receptor tyrosine kinase inhibitors in cancer therapy. J Hematol Oncol. 2019;12(1):27. https://doi.org/10.1186/s13045-019-0718-5.
Article PubMed PubMed Central Google Scholar
Zuazo-Gaztelu I, Casanovas O. Unraveling the Role of Angiogenesis in Cancer Ecosystems. Front Oncol. 2018;8:248. https://doi.org/10.3389/fonc.2018.00248.
Article PubMed PubMed Central Google Scholar
Hegde PS, Wallin JJ, Mancao C. Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics. Semin Cancer Biol. 2018;52(Pt 2):117–24. https://doi.org/10.1016/j.semcancer.2017.12.002.
CAS Article PubMed Google Scholar
Lin Z, Zhang Q, Luo W. Angiogenesis inhibitors as therapeutic agents in cancer: Challenges and future directions. Eur J Pharmacol. 2016;793:76–81. https://doi.org/10.1016/j.ejphar.2016.10.039.
CAS Article PubMed Google Scholar
Lee S, Hoang GD, Kim D, et al. Efficacy of Alpinumisoflavone Isolated from Maclura tricuspidata Fruit in Tumor Necrosis Factor-α-Induced Damage of Human Dermal Fibroblasts. Antioxidants (Basel). 2021;10(4):514. https://doi.org/10.3390/antiox10040514.
Li P-Y, Liang Y-C, Sheu M-J, et al. Alpinumisoflavone attenuates lipopolysaccharide-induced acute lung injury by regulating the effects of anti-oxidation and anti-inflammation both in vitro and in vivo. RSC Adv. 2018;8(55):31515–28. https://doi.org/10.1039/c8ra04098b.
CAS Article PubMed PubMed Central Google Scholar
Han Y, Yang X, Zhao N, Peng J, Gao H, Qiu X. Alpinumisoflavone induces apoptosis in esophageal squamous cell carcinoma by modulating miR-370/PIM1 signaling. Am J Cancer Res. 2016;6(12):2755–71.
CAS PubMed PubMed Central Google Scholar
Kuete V, Mbaveng AT, Nono EC, et al. Cytotoxicity of seven naturally occurring phenolic compounds towards multi-factorial drug-resistant cancer cells. Phytomedicine. 2016;23(8):856–63. https://doi.org/10.1016/j.phymed.2016.04.007.
CAS Article PubMed Google Scholar
Kumar S, Pathania AS, Saxena AK, Vishwakarma RA, Ali A, Bhushan S. The anticancer potential of flavonoids isolated from the stem bark of Erythrina suberosa through induction of apoptosis and inhibition of STAT signaling pathway in human leukemia HL-60 cells. Chem Biol Interact. 2013;205(2):128–37. https://doi.org/10.1016/j.cbi.2013.06.020.
CAS Article PubMed Google Scholar
Wang Y, Liu J, Pang Q, Tao D. Alpinumisoflavone protects against glucocorticoid-induced osteoporosis through suppressing the apoptosis of osteoblastic and osteocytic cells. Biomed Pharmacother. 2017;96:993–9. https://doi.org/10.1016/j.biopha.2017.11.136.
CAS Article PubMed Google Scholar
Zhang Y, Yang H, Sun M, et al. Alpinumisoflavone suppresses hepatocellular carcinoma cell growth and metastasis via NLRP3 inflammasome-mediated pyroptosis. Pharmacol Rep. 2020;72(5):1370–82. https://doi.org/10.1007/s43440-020-00064-8.
CAS Article PubMed Google Scholar
Zhang B, Fan X, Wang Z, Zhu W, Li J. Alpinumisoflavone radiosensitizes esophageal squamous cell carcinoma through inducing apoptosis and cell cycle arrest. Biomed Pharmacother. 2017;95:199–206. https://doi.org/10.1016/j.biopha.2017.08.048.
CAS Article PubMed Google Scholar
Alos HC, Billones JB, Vasquez RD, Castillo AL. Antiangiogenesis potential of alpinumisoflavone as an inhibitor of matrix metalloproteinase-9 (MMP-9) and vascular endothelial growth factor receptor-2 (VEGFR-2). Curr Enzym Inhib. 2020;15(3):159–78. https://doi.org/10.2174/1573408016666200123160509.
Dallakyan S, Olson AJ. Small-molecule library screening by docking with PyRx. Methods Mol Biol. 2015;1263:243–50. https://doi.org/10.1007/978-1-4939-2269-7_19.
CAS Article PubMed Google Scholar
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–61. https://doi.org/10.1002/jcc.21334.
CAS Article PubMed PubMed Central Google Scholar
Wang R, Lu Y, Wang S. Comparative evaluation of 11 scoring functions for molecular docking. J Med Chem. 2003;46(12):2287–303. https://doi.org/10.1021/jm0203783.
CAS Article PubMed Google Scholar
Roldan MJ, Chin T, Castillo A, Villaflores O. Cytotoxic and angiosuppresive potentials of Zehneria japonica (Thund. Ex. Murray) S.K.Chen (Cucurbitaceae) crude leaf extracts. Phil J Health Res Dev. 2018;22(1):43–52.
Udartseva OO, Zhidkova OV, Ezdakova MI, et al. Low-dose photodynamic therapy promotes angiogenic potential and increases immunogenicity of human mesenchymal stromal cells. J Photochem Photobiol B. 2019;199: 111596. https://doi.org/10.1016/j.jphotobiol.2019.111596.
CAS Article PubMed Google Scholar
Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717. https://doi.org/10.1038/srep42717.
Article PubMed PubMed Central Google Scholar
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46(1–3):3–26. https://doi.org/10.1016/s0169-409x(00)00129-0.
CAS Article PubMed Google Scholar
Veber DF, Johnson SR, Cheng HY, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45(12):2615–23. https://doi.org/10.1021/jm020017n.
CAS Article PubMed Google Scholar
Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem. 1999;1(1):55–68. https://doi.org/10.1021/cc9800071.
Muegge I, Heald SL, Brittelli D. Simple selection criteria for drug-like chemical matter. J Med Chem. 2001;44(12):1841–6. https://doi.org/10.1021/jm015507e.
CAS Article PubMed Google Scholar
Egan WJ, Merz KM Jr, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem. 2000;43(21):3867–77. https://doi.org/10.1021/jm000292e.
CAS Article PubMed Google Scholar
Santamaria S, Nuti E, Cercignani G, et al. Kinetic characterization of 4,4’-biphenylsulfonamides as selective non-zinc binding MMP inhibitors. J Enzyme Inhib Med Chem. 2015;30(6):947–54. https://doi.org/10.3109/14756366.2014.1000889.
CAS Article PubMed Google Scholar
Kenakin TP. Pharmacology in Drug Discovery and Development: Understanding Drug Response. Amsterdam: Elsevier/Academic Press; 2017.
Aertgeerts K, Skene R, Yano J, et al. Structural analysis of the mechanism of inhibition and allosteric activation of the kinase domain of HER2 protein. J Biol Chem. 2011;286(21):18756–65. https://doi.org/10.1074/jbc.M110.206193.
CAS Article PubMed PubMed Central Google Scholar
Yim-im W, Sawatdichaikul O, Semsri S, et al. Computational analyses of curcuminoid analogs against kinase domain of HER2. BMC Bioinformatics. 2014;15(1):261. https://doi.org/10.1186/1471-2105-15-261.
CAS Article PubMed PubMed Central Google Scholar
Fields GB. The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma. Cells. 2019;8(9):984. https://doi.org/10.3390/cells8090984.
CAS Article PubMed Central Google Scholar
Jacobsen JA, Major Jourden JL, Miller MT, Cohen SM. To bind zinc or not to bind zinc: an examination of innovative approaches to improved metalloproteinase inhibition. Biochim Biophys Acta. 2010;1803(1):72–94. https://doi.org/10.1016/j.bbamcr.2009.08.006.
CAS Article PubMed Google Scholar
Nanjan P, Nambiar J, Nair BG, Banerji A. Synthesis and discovery of (I-3, II-3)-biacacetin as a novel non-zinc binding inhibitor of MMP-2 and MMP-9. Bioorg Med Chem. 2015;23(13):3781–7. https://doi.org/10.1016/j.bmc.2015.03.084.
CAS Article PubMed Google Scholar
Krzeski P, Buckland-Wright C, Bálint G, et al. Development of musculoskeletal toxicity without clear benefit after administration of PG-116800, a matrix metalloproteinase inhibitor, to patients with knee osteoarthritis: a randomized, 12-month, double-blind, placebo-controlled study. Arthritis Res Ther. 2007;9(5):R109. https://doi.org/10.1186/ar2315.
CAS Article PubMed PubMed Central Google Scholar
Peterson JT. Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Heart Fail Rev. 2004;9(1):63–79. https://doi.org/10.1023/B:HREV.0000011395.11179.af.
CAS Article PubMed Google Scholar
Okamoto K, Ikemori-Kawada M, Jestel A, et al. Distinct binding mode of multi-kinase inhibitor lenvatinib revealed by biochemical characterization. ACS Med Chem Lett. 2014;6(1):89–94. https://doi.org/10.1021/ml500394m.
留言 (0)